{"slideshow_credits": null, "snippet": "Tensions inherent to drug pricing pit affordability against the need to recoup investment in research, raising questions about how much of the cost patients should have to bear....", "abstract": null, "section_name": "U.S.", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Clyde", "role": "reported", "lastname": "HABERMAN", "rank": 1, "organization": ""}], "original": "By CLYDE HABERMAN"}, "web_url": "http://www.nytimes.com/2016/12/11/us/retro-report-medical-patents-profits.html", "lead_paragraph": "Tensions inherent to drug pricing pit affordability against the need to recoup investment in research, raising questions about how much of the cost patients should have to bear.", "headline": {"main": "Lives and Profits in the Balance: The High Stakes of Medical Patents", "content_kicker": "Retro Report"}, "_id": "584deab895d0e0392607566e", "word_count": "1373", "multimedia": [{"height": 126, "url": "images/2016/12/12/us/12RETRO/12RETRO-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/12/12/us/12RETRO/12RETRO-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2016/12/12/us/12RETRO/12RETRO-articleLarge.jpg", "legacy": {"xlarge": "images/2016/12/12/us/12RETRO/12RETRO-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/12/12/us/12RETRO/12RETRO-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/12/12/us/12RETRO/12RETRO-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-12-12T00:09:21+0000", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Inventions and Patents", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Gleevec (Drug)", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Novartis AG", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Advertising and Marketing", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}